<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01288456</url>
  </required_header>
  <id_info>
    <org_study_id>PTL-1000-0005</org_study_id>
    <nct_id>NCT01288456</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Novel Gastric Space Occupying Device</brief_title>
  <official_title>A Single Centre 30-day Observational Non-randomised Study to Evaluate Preliminary Safety and Efficacy of a Novel Gastric Space Occupying Device as an Aid for Weight Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obalon Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Obalon Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be an observational, prospective, non-randomized, pilot study to gain initial
      device experience on a novel space-occupying device in persons who are overweight or obese.
      No formal hypothesis testing will be conducted.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">10</enrollment>
  <condition>Obesity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from a community sample that satisfy the inclusion/exclusion
        criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 21-64 years

          2. BMI 27-40 Kg/m2

          3. No history of weight reduction of more than 5% of total body weight in the past 6
             months

        Exclusion Criteria:

          1. Have unstable angina, myocardial infarction within the past year, or heart disease
             classified within the New York Heart Association's Class III or IV functional
             capacity;

          2. Be taking chronic aspirin or other non steroidal anti-inflammatory agents, or other
             medications known to be gastric irritants, and unwillingness to discontinue the use of
             these concomitant medications, antiarrythmics, anti-anginal medications,
             anticoagulants or medications for congestive heart failure;

          3. Be taking blood pressure medications, unless their blood pressure is controlled and
             they have been at stable dose for at least 3 months;

          4. Have type 1 diabetes or type 2 diabetes requiring oral medications or insulin;

          5. History or symptoms of thyroid disease which is not controlled by medication;

          6. Have severe renal, hepatic, pulmonary disease or cancer;

          7. Past history of gastrointestinal surgery (excluding uncomplicated appendectomy);

          8. Have a history of adhesive peritonitis;

          9. History or symptoms of esophageal and/or gastric varices;

         10. Have history or congenital or acquired GI anomalies (e.g. atresias, stricture, and /or
             diverticula);

         11. History or symptoms of inflammatory bowel disease, such as Chron's disease;

         12. History of/ signs and /or symptoms of duodenal or gastric ulcer;

         13. Have gastroparesis;

         14. Pregnant or breastfeeding or intention of becoming pregnant during the study (if
             female of childbearing potential);

         15. Currently using pharmaceutical agents for weight loss;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel Ortiz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Obesity Control Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Obesity Control Center</name>
      <address>
        <city>Tijuana</city>
        <state>Baja California</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2011</study_first_submitted>
  <study_first_submitted_qc>February 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2011</study_first_posted>
  <last_update_submitted>May 25, 2012</last_update_submitted>
  <last_update_submitted_qc>May 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>medical device, space-occupying device</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

